Engaging the justice system to address the opioid crisis: The Justice Community Opioid Innovation Network (JCOIN).
Engaging the justice system to address the opioid crisis: The Justice Community Opioid Innovation Network (JCOIN).
复制标题
让司法系统参与解决阿片类药物危机：司法社区阿片类药物创新网络（JCOIN）。
DOI：
10.1016/j.jsat.2021.108307
复制
发表时间：
2021-09
影响因子：
3.9
通讯作者：
Zur, Julia B.
中科院分区：
文献类型：
--
作者：
Ducharme, Lori J.;Wiley, Tisha R. A.;Mulford, Carrie F.;Su, Zu-In;Zur, Julia B.
每年，许多阿片类药物使用障碍患者接触司法系统，使刑事司法系统和医疗保健系统之间的联系成为应对阿片类药物危机并同时促进公共卫生和公共安全的关键节点。这些部门之间的合作对于以下方面至关重要：提供有效的筛查、治疗和出院规划；将个人与释放后的服务联系起来；促进长期康复，同时减少再次犯罪；并最终控制阿片类药物危机。2019年，在NIH帮助结束成瘾长期倡议(Hear)的支持下，国家药物滥用研究所启动了正义社区阿片类药物创新网络(JCOIN)。JCOIN是一家耗资1.5亿美元的多站点合作机构，旨在促进跨学科合作，为司法系统和社区组织提供可操作、可翻译的见解，以应对涉及司法的人群中阿片类药物的流行。JCOIN汇集了11个研究中心、一个协调和翻译中心(CTC)以及一个方法和高级分析资源中心(MAARC)，目的是产生比各部分之和更大的证据。总体而言，该网络将开展至少12项大规模多地点临床试验，本期特刊对此进行了描述。本文简要概述了这些试验的科学基础；描述了连接这些试验的广泛主题；并讨论了JCOIN倡议与新冠肺炎大流行的交集。
Many individuals with opioid use disorder come into contact with the justice system each year, making the nexus between the criminal justice system and the healthcare system a critical juncture for responding to the opioid crisis and simultaneously promoting public health and public safety. Collaborations across these sectors are essential to providing effective screening, treatment, and discharge planning; connecting individuals to services following release; promoting long-term recovery while reducing recidivism; and ultimately bringing the opioid crisis under control. In 2019, with the support of the NIH Helping to End Addiction Long-term (HEAL) Initiative, the National Institute on Drug Abuse launched the Justice Community Opioid Innovation Network (JCOIN). JCOIN is a >$150M multisite cooperative designed to facilitate transdisciplinary collaborations that can create actionable, translatable insights for the justice system and community-based organizations to address the opioid epidemic in justice-involved populations. JCOIN brings together 11 Research Hubs, a Coordination and Translation Center (CTC), and a Methodology and Advanced Analytics Resource Center (MAARC), with the goal of generating evidence that is greater than the sum of the parts. Collectively, the network will field at least 12 large-scale multi-site clinical trials, which are described in this special issue. This article provides a brief overview of the scientific underpinnings for these trials; describes the broad themes connecting them; and discusses the intersections of the JCOIN initiative with the COVID-19 pandemic.
登录
查看更多内容
影响因子：
3.9
作者：
Molfenter T;Vechinski J;Taxman FS;Breno AJ;Shaw CC;Perez HA
通讯作者：
Perez HA
影响因子：
3.9
作者：
Waddell EN;Springer SA;Marsch LA;Farabee D;Schwartz RP;Nyaku A;Reeves R;Goldfeld K;McDonald RD;Malone M;Cheng A;Saunders EC;Monico L;Gryczynski J;Bell K;Harding K;Violette S;Groblewski T;Martin W;Talon K;Beckwith N;Suchocki A;Torralva R;Wisdom JP;Lee JD
通讯作者：
Lee JD
影响因子：
3.9
作者：
Aalsma MC;Aarons GA;Adams ZW;Alton MD;Boustani M;Dir AL;Embi PJ;Grannis S;Hulvershorn LA;Huntsinger D;Lewis CC;Monahan P;Saldana L;Schwartz K;Simon KI;Terry N;Wiehe SE;Zapolski TCB
通讯作者：
Zapolski TCB
影响因子：
3.9
作者：
Martin RA;Stein LAR;Rohsenow DJ;Belenko S;Hurley LE;Clarke JG;Brinkley-Rubinstein L
通讯作者：
Brinkley-Rubinstein L
影响因子：
3.6
作者：
Blachman-Demner, Dara R.;Wiley, Tisha R. A.;Chambers, David A.
通讯作者：
Chambers, David A.